Precigen (PGEN) Operating Expenses (2012 - 2026)

Precigen (PGEN) has reported Operating Expenses for 15 consecutive years, with $32.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses fell 0.87% year-over-year to $32.3 million in Q2 2026; TTM through Jun 2026 was $125.2 million, a 15.43% increase from a year earlier, with the FY2025 full-year figure at $120.2 million, down 13.5% from the prior year.
• Operating Expenses was $32.3 million for Q2 2026 at Precigen, up from $29.2 million in the prior quarter.
• Over five years, Operating Expenses peaked at $61.6 million in Q2 2024 and troughed at $22.2 million in Q3 2024.
• A 5-year average of $29.4 million and a median of $26.7 million in 2022 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 168.96% in 2024 and plunged 47.01% in 2025, its largest moves.
• Over 5 years, Operating Expenses stood at $23.6 million in 2022, then jumped by 50.48% to $35.5 million in 2023, then dropped by 16.21% to $29.7 million in 2024, then decreased by 11.7% to $26.2 million in 2025, then gained by 23.27% to $32.3 million in 2026.
• The last three Operating Expenses figures came in at $32.3 million (Q2 2026), $29.2 million (Q1 2026), and $26.2 million (Q4 2025), per Business Quant data.